A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD.

Socié, Gérard

A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. [electronic resource] - Blood 02 2017 - 643-649 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1528-0020

10.1182/blood-2016-09-738625 doi


Acute Disease
Adult
Antibodies, Monoclonal--adverse effects
Antilymphocyte Serum--adverse effects
Drug Resistance
Female
Graft vs Host Disease--drug therapy
Humans
Immunosuppressive Agents--adverse effects
Male
Middle Aged
Proportional Hazards Models
Steroids--therapeutic use
Survival Analysis
Treatment Outcome